As of January 22, 2025, Collegium Pharmaceutical (COLL) has a market cap of $1.05 billion USD. According to our data, Collegium Pharmaceutical is ranked No.5128 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.05 B |
13.61%
|
Dec 31, 2024 | $0.92 B |
-6.92%
|
Dec 29, 2023 | $0.99 B |
32.67%
|
Dec 30, 2022 | $0.75 B |
24.20%
|
Dec 31, 2021 | $0.60 B |
-6.74%
|
Dec 31, 2020 | $0.65 B |
-2.67%
|
Dec 31, 2019 | $0.66 B |
19.86%
|
Dec 31, 2018 | $0.55 B |
-6.99%
|
Dec 29, 2017 | $0.60 B |
18.56%
|
Dec 30, 2016 | $0.50 B |
-43.38%
|
Dec 31, 2015 | $0.89 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
Amneal Pharmaceuticals
AMRX
|
$3.94 B |
1.296 B
|
USA
|
Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Market Cap | = | COLL Stock Price | * | COLL Shares Outstanding |
= | $32.55 | * | 32.25 M | |
= | $1.05 B |